This site is best viewed with Internet Explorer 6.0 or higher, Firefox 2.0 or higher at a minimum screen resolution of 1024x768.
Copyright PatIntNews.Com 2007. All Right Reserved
A team of scientists with Professor David Parker at Durham University in UK, with scientists from the University of Maryland in US, are developing a test for prostate cancer that uses the prostate fluid taken under local anaesthesia from the patient and takes 3 minutes for detection by measuring the levels of citrate and lactate as biomarkers of the disease.
A team of Australian and Korean researchers led by Geoffrey M. Spinks and Seon Jeong Kim has now developed a novel, highly porous, sponge-like material whose mechanical properties mimic those of biological soft tissues. It consists of a robust network of DNA strands and carbon nanotubes.
Phytoremediation is a type of bioremediation in which plants sequester or biodegrade environmental contaminants. In the recent years this technology has advanced with an extensive development towards removal of arsenic, nickel, petroleum hydrocarbons, pesticides and other metals and chemicals, from soil and ground water.
Competitive Technologies, Inc. (NYSE Amex:CTT) announced today that it has got a third patent for its bone nanoparticle biomaterial technology. This patent supports the first two patents and provides
additional claims regarding the preparation of the primary components of the bone cement.
PolyOne Corporation and Zyvex Performance Materials proclaimed $4.9 million grant from the Ohio Third Frontier Commission for further development and production of carbon-nanotube composites.
Pharma major Lupin Ltd has received 20 million euros from a patent deal with French drug firm Laboratories Servier. ''The income from this sale significantly boosts our performance for the previous quarter. It goes a long way to demonstrate our Research and Intellectual Property (IP) capabilities,'' Lupin Managing Director Kamal Sharma said.
